Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

February 2, 2011

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice. See also Rodent of the Week: A different approach to treating Type 1 diabetes and Destroying Glucagon Receptors May Cure Diabetes.
Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase. (See also Halozyme Therapeutics Endocrinology Product Pipeline for more information.)
The Possible Protective Role of Glucagon-Like Peptide 1 on Endothelium During the Meal and Evidence for an “Endothelial Resistance” to Glucagon-Like Peptide 1 in Diabetes
.
Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes.
Of Mouse & Man: Frustrations and Excitements in Diabetes Research. (Requires Facebook account)

January 26, 2011

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.
Tests for Genetic Interactions in Type 1 Diabetes; Linkage and Stratification Analyses of 4,422 Affected Sib-Pairs.
Coexistent Autoimmunity in Familial Type 1 Diabetes: Increased Susceptibility in Sib-Pairs?

January 19, 2011

Researchers find the enzyme at the heart of retinopathy caused by type 1 or type 2 diabetes. See also Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy.
Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes.
Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
Effect of Automated Bio-Behavioral Feedback on the Control of Type 1 Diabetes.
Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model.

January 12, 2011

On the Occurrence of the Diabetes-Associated Antigen GAD 65 in Human Sera.
A novel technique for the in vivo imaging of autoimmune diabetes development in the pancreas by two-photon microscopy. Free full text available in HTML and PDF formats.
Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes.
Genetics of Type 1 Diabetes.
Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes.
Correction of Hyperglycemia in Type 1 Diabetic Models by Transplantation of Encapsulated Insulin-producing Cells Derived from Mouse Embryo Progenitor.

January 5, 2011

HbA(1c) levels in schoolchildren with type 1 diabetes are seasonally variable and dependent on weather conditions.
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera. Free full text available in HTML and PDF formats.
Effects of Serving High-Sugar Cereals on Children’s Breakfast-Eating Behavior.

December 29, 2010

Association of coxsackie virus infection and T lymphocyte subset changes with type 1 diabetes. Free full text available in PDF format.
Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus.

December 22, 2010

Birth order and childhood type 1 diabetes risk: a pooled analysis of 31 observational studies.
Exenatide, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic beta-cell destruction induced by encephalomyocarditis virus.
Left ventricular diastolic dysfunction in adolescents with type 1 diabetes reflects the long- but not short-term metabolic control.
A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000-2008.
Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025.
Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis.
Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans.
Attenuation of Diabetes-Induced Cardiac Inflammation and Pathological Remodeling by Low-Dose Radiation.
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up.

December 15, 2010

Analysis of pathogenesis of juvenile new onset diabetes.
Cells reprogrammed to treat diabetes;
Testes may be a source of insulin production. See also “Grow Your Own Transplant” May be Possible for Men with Type 1 Diabetes, Stem Cells Turned Into Complex, Functioning Intestinal Tissue in Lab, Stem Cells Used to Make Pancreas, Gut Cells and Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.

December 8, 2010

Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial.
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
Efficacy Determinants of Subcutaneous Microdose Glucagon during Closed-Loop Control.
Factors influencing the effectiveness of glucagon for preventing hypoglycemia.

December 1, 2010

Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes The Allegheny County Type 1 Diabetes Registry. See also Type 1 Diabetes Death Rate is Falling, But Not Fast Enough.
Preclinical arterial disease in patients with type 1 diabetes without other major cardiovascular risk factors or macro-microvascular disease.
Danish children born 1981-2002 with GAD65 and IA-2 autoantibodies at birth had an increased risk to develop type 1 diabetes before 2004.
Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited.
Detection of nocturnal hypoglycemic episodes using EEG signals.

« Previous
1
…
61
62
63
64
65
…
94
Next »

advertisement

Last Updated: Tuesday, June 17, 2025 19:04:20 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Email
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Name
This field is for validation purposes and should be left unchanged.